Do not use bisphosphonates without scientific evidence, neither in treatment nor prophylactic, in the treatment of stress fractures

Knee Surgery, Sports Traumatology, Arthroscopy

Volumn 17, Issue 5, 2009, Pages 433-434

  Ekenman, Ingrid ^a  

^a NONE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

ANIMAL; BONE REMODELING; DRUG CONTRAINDICATION; DRUG EFFECT; EDITORIAL; EVIDENCE BASED MEDICINE; FRACTURE HEALING; HUMAN; STRESS FRACTURE;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; DIPHOSPHONATES; EVIDENCE-BASED MEDICINE; FRACTURE HEALING; FRACTURES, STRESS; HUMANS;

EID: 67349113455     PISSN: 09422056     EISSN: 14337347     Source Type: Journal    
DOI: 10.1007/s00167-009-0742-z     Document Type: Editorial

References (17)

1. KL Bennell SA Malcolm PD Brukner RM Green JL Hopper JD Wark PR Ebeling 1998 A 12-month prospective study of the relationship between stress fractures and bone turnover in athletes Calcif Tissue Int 63 80 85
2. DB Burr C Milgrom RD Boyd WL Higgins G Robin EL Radin 1990 Experimental stress fractures of the tibia. Biological and mechanical aetiology in rabbits J Bone Joint Surg Br 72 370 375
3. DB Burr MR Forwood DP Fyhrie RB Martin MB Schaffler CH Turner 1997 Bone microdamage and skeletal fragility in osteoporotic and stress fractures J Bone Miner Res 12 6 15
4. Burr DB (2001) Pharmaceutical treatments that may prevent or delay the onset of stress fractures. In: Burr DB, Milgrom C (eds) Muscloskeletal fatigue and stress fractures. CRC Press, Boca Raton, pp 259-270
5. R Korpelainen S Orava J Karpakka P Siira A Hulkko 2001 Risk factors for recurrent stress fractures in athletes Am J Sports Med 29 304 310
6. AH Kurth C Eberhardt S Müller M Steinacker M Schwarz F Bauss 2005 The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats Bone 37 204 210
7. BA Lenart DG Lorich JM Lane 2008 Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate N Engl J Med 358 1304 1306
8. T Mashiba CH Turner T Hirano MR Forwood CC Johnston DB Burr 2001 Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles Bone 28 524 531
9. C Milgrom A Simkin A Eldad M Nyska A Finestone 2000 Using bone's adaptation ability to lower the incidence of stress fractures Am J Sports Med 28 245 251
10. C Milgrom A Finestone N Sharkey A Hamel V Mandes D Burr A Arndt I Ekenman 2002 Metatarsal strains are sufficient to cause fatigue fracture during cyclic overloading Foot Ankle Int 23 230 235
11. C Milgrom A Finestone V Novack D Pereg Y Goldich Y Kreiss E Zimlichman S Kaufman M Liebergall D Burr 2004 The effect of prophylactic treatment with risedronate on stress fracture incidence among infantry recruits Bone 35 418 424
12. O Miltner C Niedhart W Piroth M Weber CH Siebert 2003 Transient osteoporosis of the navicular bone in a runner Arch Orthop Trauma Surg 123 505 508
13. SM Ott 2001 Fractures after long-term alendronate therapy J Clin Endocrinol Metab 86 1835 1836
14. M Pepper V Akuthota EC [tmp] McCarty 2006 The pathophysiology of stress fractures Clin Sports Med 25 1 16
15. JD Ringe JJ Body 2007 A review of bone pain relief with ibandronate and other bisphosphonates in disorders of increased bone turnover Clin Exp Rheumatol 25 766 774
16. M Taki O Iwata M Shiono M Kimura K Takagishi 2007 Extracorporeal shock wave therapy for resistant stress fracture in athletes: a report of 5 cases Am J Sports Med 35 1188 1192
17. DK Wysowski J Chang 2005 Alendronate and risedronate: reports of severe bone, joint, and muscle pain Arch Intern Med 165 346 347